---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-029094"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T08:31:37.405430+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics Q3 revenue up 38% to $4.6M; net loss narrows to $0.24/share

## Summary
- Revenue of $4.6M, up 38% YoY; gross margin improved to 53% from 51%.
- Net loss narrowed to $3.4M ($0.24 per share) from $4.3M ($0.33) in Q3 2022.
- Sold 41 EksoHealth devices, including a record quarter of EVO unit sales.
- Cash on hand $9.9M at Sep 30, 2023, down from $20.5M at Dec 31, 2022.
- Company applied for CMS code determination for Indego Personal exoskeleton.

## SEC filing metadata
- accession: 0001437749-23-029094
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/0001437749-23-029094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/ekso20231024c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-029094
- JSON: https://secwatch.observer/filing/0001437749-23-029094.json
- Plain text: https://secwatch.observer/filing/0001437749-23-029094.txt

## Key facts
- Earnings Releases
  EKSO BIONICS HOLDINGS, INC. reported financial results for the three and nine months ended September 30, 2023.
  - Period: the three and nine months ended September 30, 2023
  - Result: reported results
  source text: On October 26, 2023 Ekso Bionics Holdings, Inc. (the “Company”) reported its financial results for the three and nine months ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/0001437749-23-029094-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.